NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Odne

Odne

Private
DübendorfHealthcare & Life Scienceshttps://odne.co/

Last Round

Series A

Extension

Jun 12, 2025

Total Funding Raised

$14.43M

Company Overview

Odne is a medical technology company that develops transformative endodontic solutions, including its Root Preservation Therapy (RPT) platform for root canal treatments.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

endodonticsroot canal treatmentdental medical deviceendodontic workflowroot canal cleaningobturationultrasonic irrigationlight-cured fillingdental consumableshydrodynamic cavitationendo toolsroot canal techdental hardwareendodontic supplies

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Odne Comparables

Compare Odne with similar companies based on industry and business-model similarity.

Odne comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sonendo, Inc.
85%
EdgeEndo
85%
Henry Schein, Inc.
77%

Odne Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJun 12, 2025
Series A ExtensionMar 13, 2024
SeedJun 1, 2022
DebtOct 3, 2019
GrantNov 7, 2017

Key People

Founding team and executive leadership

Mark Bispinghoff

COO Co-founder

Founding Team

Odne Investors

Notable investors and investment history

Odne investors
InvestorRounds
Foundation for Technological InnovationDebt
Plug and Play Tech CenterSeries A Extension
Hatcher+Series A Extension
Business Angels SwitzerlandSeed
N & V CapitalSeed
Revere PartnersSeed, Series A Extension
Venture KickGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2025

    Products have received clearance from the U.S. Food and Drug Administration.

  • Oct 1, 2025

    Achieved certification for medical device quality management systems.

Odne Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Odne Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Odne's valuation, stock price, and market status.

Firmographic Details

HeadquartersDübendorf
Employee Range18
Year Founded2018
Last FundingJun 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.